{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:25:49Z","timestamp":1785583549478,"version":"3.56.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9-10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Women make up 16.3% of the Department of Defense (DoD) active duty military population. January 2016, the Secretary of the Defense opened all military positions to women, including combat positions. Identifying conditions that may impact health and military readiness are essential to maintaining a fit and ready force. Polycystic ovary syndrome (PCOS) is a condition that has significant health and military readiness implications for active duty service women (ADSW). Some of the common manifestations of PCOS, overweight, obesity, and abnormal menstrual cycles, have a direct impact on the deployment readiness of ADSW, which effects military operations. The prevalence of PCOS in ADSW must be identified to ascertain true numbers in the DoD to appropriately support, treat, and manage this population; therefore, the purpose of this study was to explore the prevalence of PCOS diagnosis, in ADSW.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>A retrospective analysis of electronic health record data from the Department of Defense Military Health Systems DataMart was conducted for calendar years January 2011 \u2013 December 2016, using ICD 9 and 10 codes. ADSW with symptoms and conditions that were present with PCOS but did not have the ICD 9 or 10 code for PCOS were also identified to explore the potential undiagnosed prevalence of PCOS. The diagnosed symptoms and conditions included for analysis were weight gain, obesity, dyslipidemia, glucose intolerance, hypertension, acne, acanthosis nigricans, infertility, and menstrual irregularity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There are 11,190 (0.2%) ADSW diagnosed with PCOS, and 9,112 (0.17%) diagnosed with symptoms that meet the profile and characteristics present in PCOS, but have no diagnosis. All branches of service and ranks were represented in these numbers<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>PCOS is present in ADSW. Obtaining an accurate prevalence rate of this condition helps reveal the extent of its presence, helps increase awareness, and identify that there is a population in need of targeted support and interventions to maintain a fit and ready force.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usz023","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T18:24:45Z","timestamp":1551291885000},"page":"440-446","source":"Crossref","is-referenced-by-count":10,"title":["Polycystic Ovary Syndrome in Active Duty Service Women: A Retrospective Analysis"],"prefix":"10.1093","volume":"184","author":[{"given":"Dawnkimberly","family":"Hopkins","sequence":"first","affiliation":[{"name":"David Grant Medical Center, 101 Bodin Circle, Travis AFB, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candy","family":"Wilson","sequence":"additional","affiliation":[{"name":"Graduate School of Nursing, Uniformed Services University, 4301 Jones Bridge Road, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"2020011208563020700_usz023C1","author":"Defense Manpower Data Center","year":"2015"},{"issue":"6","key":"2020011208563020700_usz023C2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020011208563020700_usz023C3","first-page":"S65","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"key":"2020011208563020700_usz023C4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"issue":"1","key":"2020011208563020700_usz023C5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"issue":"1","key":"2020011208563020700_usz023C6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mcna.2014.09.003","article-title":"Polycystic ovarian syndrome","volume":"99","author":"Trikudanathan","year":"2015","journal-title":"Med Clin North Am"},{"issue":"1","key":"2020011208563020700_usz023C7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"ESHRE","year":"2004","journal-title":"Fertil Steril"},{"issue":"2","key":"2020011208563020700_usz023C8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"5","key":"2020011208563020700_usz023C9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"2020011208563020700_usz023C10","first-page":"28","article-title":"Brief report: polycystic ovary syndrome, active component service women, U.S. Armed Forces, 2000\u20132012","volume":"20","author":"Report","year":"2013","journal-title":"Med Surveill Mon Rep"},{"issue":"1","key":"2020011208563020700_usz023C11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.fertnstert.2009.09.025","article-title":"Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)","volume":"94","author":"Bhattacharya","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"2020011208563020700_usz023C12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.fertnstert.2007.11.022","article-title":"Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study","volume":"91","author":"Kerchner","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"2020011208563020700_usz023C13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/01674820802546204","article-title":"Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome","volume":"30","author":"Laggari","year":"2009","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"3","key":"2020011208563020700_usz023C14","first-page":"356","article-title":"Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls","volume":"66","author":"Weiner","year":"2004","journal-title":"Psychosom Med"},{"issue":"5","key":"2020011208563020700_usz023C15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum Reprod"},{"issue":"6","key":"2020011208563020700_usz023C16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7205\/MILMED-D-15-00187","article-title":"Mental health and comorbidities in U.S. military members","volume":"181","author":"Crum-Cianflone","year":"2016","journal-title":"Mil Med"},{"issue":"4","key":"2020011208563020700_usz023C17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.whi.2010.03.002","article-title":"Military women\u2019s attitudes toward menstruation and menstrual suppression in relation to the deployed environment: development and testing of the MWATMS-9 (short form)","volume":"20","author":"Trego","year":"2010","journal-title":"Womens Health Issues"},{"issue":"2","key":"2020011208563020700_usz023C18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1552-6909.2012.01347.x","article-title":"Exploring the patterns, practices, and experiences of military women who managed genitourinary symptoms in deployed settings","volume":"41","author":"Wilson","year":"2012","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"4","key":"2020011208563020700_usz023C19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1745-7599.2001.tb00245.x","article-title":"A military challenge to managing feminine and personal hygiene","volume":"13","author":"Wardell","year":"2001","journal-title":"J Am Acad Nurse Pract"},{"key":"2020011208563020700_usz023C20","author":"USAF Medical Standards Directory (MSD)","year":"2018"},{"key":"2020011208563020700_usz023C21","author":"AR 40\u2013501 Medical Services Standards of Medical Fitness","year":"2017"},{"key":"2020011208563020700_usz023C22","author":"Manual of the Medical Department","year":"2018"},{"key":"2020011208563020700_usz023C23","author":"Air Force Waiver Guide","year":"2018"},{"key":"2020011208563020700_usz023C24","author":"Air Force\u2019s Personnel Center","year":"2018"},{"issue":"2","key":"2020011208563020700_usz023C25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-09-0733","article-title":"Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome","volume":"162","author":"Diamanti-Kandarakis","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2020011208563020700_usz023C26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"2020011208563020700_usz023C27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2005.03.010","article-title":"Obesity and extreme obesity, manifest by ages 20\u201324 years, continuing through 32\u201341 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy","volume":"122","author":"Glueck","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2020011208563020700_usz023C28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.fertnstert.2011.11.026","article-title":"Do women with PCOS have a unique predisposition to obesity?","volume":"97","author":"Hoeger","year":"2012","journal-title":"Fertil Steril"},{"key":"2020011208563020700_usz023C29","author":"Air Force Instruction 36\u20132905 Fitness Program","year":"2013"},{"key":"2020011208563020700_usz023C30","author":"OPNAV Instruction 6110.1J Physical Readiness Program","year":"2011"},{"key":"2020011208563020700_usz023C31","author":"FM 7\u201322 Army Physical Readiness Training","year":"2012"},{"key":"2020011208563020700_usz023C32","first-page":"18","volume-title":"Air Force Times","author":"Tilghman","year":"2016"},{"issue":"8","key":"2020011208563020700_usz023C33","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020011208563020700_usz023C34","author":"Health.mil","year":"2018"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/9-10\/440\/31799055\/usz023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/9-10\/440\/31799055\/usz023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,12]],"date-time":"2020-01-12T13:57:08Z","timestamp":1578837428000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/184\/9-10\/440\/5366285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":34,"journal-issue":{"issue":"9-10","published-online":{"date-parts":[[2019,2,27]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usz023","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,2,27]]}}}